| 注册
首页|期刊导航|中国药物评价|大七厘散的质量标准研究

大七厘散的质量标准研究

陈惠玲 胡珊梅 陈洁 李玲玲 黄惠琼

中国药物评价Issue(2):83-86,4.
中国药物评价Issue(2):83-86,4.

大七厘散的质量标准研究

Study of the Quality Standards of Daqili Powder

陈惠玲 1胡珊梅 1陈洁 1李玲玲 1黄惠琼1

作者信息

  • 1. 厦门市药品检验所,福建厦门361012
  • 折叠

摘要

Abstract

Objective:To establish quality control for Daqili Powder.Methods: Rhei Radix et Rhizoma, Angelicae sinensis Radix, Borneolum Syntheticum,Notoginseng Radix et Rhizoma, Drynariae Rhizoma in Daqili Powder were identified by TLC,and draorhodin was determined by HPLC.Test solution was made with 12%phosphoric acid in methanol,Use a mixture of acetonitrile and 0.05 mol· L-1 so-dium dihydrogen phosphate solution (50∶50) as the mobile phase.As detector a spectrophotometer set at 440 nm.Results:The calibration curves were linear within the range of 0.774~77.415 μg· mL-1 ( r=0.9999 ).The average recovery was 100.2% with RSD was 1.8%( n=9).Conclusion:The method is sensitive and accurate,and it is suitable for the quality control of Daqili Powder.

关键词

大七厘散/血竭素/大黄/当归/冰片/三七/骨碎补/质量标准

Key words

Daqili Powder/Dracorhodin/Rhei Radix et Rhizoma/Angelicae sinensis Radix/Borneolum Syntheticum/Notoginseng Radix et Rhizoma/Drynariae Rhizoma/Quality control

分类

医药卫生

引用本文复制引用

陈惠玲,胡珊梅,陈洁,李玲玲,黄惠琼..大七厘散的质量标准研究[J].中国药物评价,2015,(2):83-86,4.

基金项目

2012年厦门市重大科技项目,项目编号3502Z20121035 ()

中国药物评价

2095-3593

访问量0
|
下载量0
段落导航相关论文